Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Infection, Response to Therapy of”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Post-approval studies (Phase 4)WithdrawnNCT01770223
What this trial is testing

Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01604850
What this trial is testing

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 202
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Testing effectiveness (Phase 2)Study completedNCT01888900
What this trial is testing

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

Who this might be right for
CirrhosisChronic Hepatitis CHepatitis C+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 35
Testing effectiveness (Phase 2)Study completedNCT00869661
What this trial is testing

RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 413
Large-scale testing (Phase 3)Study completedNCT00215865
What this trial is testing

PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy

Who this might be right for
Chronic Hepatitis C Virus Infection
Hepatitis Resource Network 600
Not applicableUnknownNCT04768517
What this trial is testing

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus (HIV) Coinfection
National Taiwan University Hospital 300
Not applicableUnknownNCT01572233
What this trial is testing

Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
National Taiwan University Hospital 300
Not applicableStudy completedNCT00700401
What this trial is testing

POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 262
Not applicableEnded earlyNCT00871845
What this trial is testing

Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients

Who this might be right for
ObesityInsulin ResistanceMetabolic Syndrome+1 more
Hossam Kandil 36
Testing effectiveness (Phase 2)Study completedNCT00085917
What this trial is testing

Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected Patients

Who this might be right for
Hepatitis CHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)Study completedNCT00055341
What this trial is testing

Treatment of Hepatitis C in Hemophilic Patients With HIV

Who this might be right for
HIV InfectionsHepatitis CHemophilia
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT02185794
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 101
Not applicableLooking for participantsNCT05361603
What this trial is testing

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Who this might be right for
Hepatitis CTransmission, Intravenous Drug AbuserAddiction, Alcohol+2 more
University Hospital, Limoges 1,500
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Post-approval studies (Phase 4)Study completedNCT00938860
What this trial is testing

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

Who this might be right for
Hepatitis CLiver Transplantation
Novartis Pharmaceuticals 92
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Testing effectiveness (Phase 2)Ended earlyNCT00840489
What this trial is testing

Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis

Who this might be right for
Chronic Hepatitis C
Hospital Universitario Ramon y Cajal 50
Testing effectiveness (Phase 2)Study completedNCT01482403
What this trial is testing

Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 58
Post-approval studies (Phase 4)Ended earlyNCT00456248
What this trial is testing

Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin

Who this might be right for
Hepatitis C
Kadmon Corporation, LLC 5
Load More Results